Last updated: October 2026
Tirzepatide Dosage Calculator
Quick answer: A 5 mg dose from a 10 mg/mL compounded vial is 0.50 mL = 50 units on a U-100 syringe. Formula: Volume (mL) = Dose (mg) ÷ Concentration (mg/mL), and units = mL × 100.
About this calculator
This tirzepatide dose calculator turns a weekly dose between 2.5 and 15 mg into the volume to draw from a compounded vial, using Volume (mL) = Dose (mg) ÷ Concentration (mg/mL). It shows the result in mL and in U-100 syringe units for 2.5, 5 and 10 mg/mL vials, plus custom strengths. Tirzepatide moves in 2.5 mg steps across six doses, so a single vial strength produces six different draws, and at the upper steps many of them come to more than 100 units. It is built for compounded vials, not Mounjaro or Zepbound pens. Free, instant, no login. Mixing a powder vial yourself? Find the concentration first with the reconstitution calculator.
How to use this calculator
You need two numbers: the vial strength printed on your pharmacy label in mg/mL, and the weekly dose your prescriber gave you in mg.
Pick the strength with the preset buttons or type a custom one, then set the dose with the slider. The draw in mL and in units updates at once. The steps run 2.5, 5, 7.5, 10, 12.5 and 15 mg, so at 10 mg/mL the draw climbs from 0.25 mL to 1.50 mL, and the last two steps pass the 100 units that a 1 mL syringe holds.
Check the result against the markings on your own syringe before you inject. Units assume a U-100 insulin syringe (1 unit = 0.01 mL).
Worked examples in tirzepatide units
Vial concentration: 10 mg/mL
Prescribed dose: 2.5 mg
Draw = 2.5 ÷ 10 = 0.25 mL = 25 units (U-100 syringe)
Vial concentration: 10 mg/mL
Prescribed dose: 7.5 mg
Draw = 7.5 ÷ 10 = 0.75 mL = 75 units (U-100 syringe)
Vial concentration: 5 mg/mL
Prescribed dose: 10 mg
Draw = 10 ÷ 5 = 2.00 mL = 200 units, which is more than a 1 mL syringe holds
Vial concentration: 10 mg/mL
Prescribed dose: 15 mg
Draw = 15 ÷ 10 = 1.50 mL = 150 units, again above a 1 mL syringe
Vial: 10 mg/mL × 3 mL = 30 mg
Prescribed dose: 5 mg
Doses = 30 ÷ 5 = 6 weekly doses, each 0.50 mL = 50 units
Common dose reference table
| Dose | 2.5 mg/mL vial | 5 mg/mL vial | 10 mg/mL vial |
|---|---|---|---|
| 2.5 mg | 1.00 mL (100 U) | 0.50 mL (50 U) | 0.25 mL (25 U) |
| 5 mg | 2.00 mL (200 U) | 1.00 mL (100 U) | 0.50 mL (50 U) |
| 7.5 mg | 3.00 mL (300 U) | 1.50 mL (150 U) | 0.75 mL (75 U) |
| 10 mg | 4.00 mL (400 U) | 2.00 mL (200 U) | 1.00 mL (100 U) |
| 12.5 mg | 5.00 mL (500 U) | 2.50 mL (250 U) | 1.25 mL (125 U) |
| 15 mg | 6.00 mL (600 U) | 3.00 mL (300 U) | 1.50 mL (150 U) |
Need the syringe mark for a single dose? Tirzepatide units chart, 2.5 to 15 mg →
Typical tirzepatide titration schedule
Standard compounded vial protocol. Your prescriber sets your actual schedule — titration timing and doses vary. Full titration guide →
| Step | Dose | Typical weeks | mg used in 4 weekly doses | Draw at 10 mg/mL |
|---|---|---|---|---|
| 1 | 2.5 mg | 1–4 | 10 mg | 0.25 mL (25 U) |
| 2 | 5 mg | 5–8 | 20 mg | 0.50 mL (50 U) |
| 3 | 7.5 mg | 9–12 | 30 mg | 0.75 mL (75 U) |
| 4 | 10 mg | 13–16 | 40 mg | 1.00 mL (100 U) |
| 5 | 12.5 mg | 17–20 | 50 mg | 1.25 mL (125 U) |
| 6 | 15 mg | 21+ | 60 mg | 1.50 mL (150 U) |
Weeks are typical, not a rule. The “mg used” column shows how much of a vial four weekly doses at that step take, so you can see when to reorder.
Vial strengths and pen equivalents
The number of weekly doses in a vial is its total mg (strength × volume) divided by the dose, rounded down. Common compounded tirzepatide vials give:
| Vial label | Total | 2.5 mg doses | 5 mg doses | 10 mg doses |
|---|---|---|---|---|
| 10 mg/mL × 2 mL | 20 mg | 8 | 4 | 2 |
| 10 mg/mL × 3 mL | 30 mg | 12 | 6 | 3 |
| 5 mg/mL × 4 mL | 20 mg | 8 | 4 | 2 |
| 2.5 mg/mL × 4 mL | 10 mg | 4 | 2 | 1 |
Each Zepbound pen or single-dose vial strength is its dose in 0.5 mL. A 5 mg pen holds the same 5 mg that a 10 mg/mL compounded vial gives as 0.50 mL = 50 units, but the pen is injected as supplied and needs no draw.
How tirzepatide differs from semaglutide
The formula is identical, but the numbers are not. Tirzepatide runs from 2.5 to 15 mg in six steps, while semaglutide runs from 0.25 to 2.4 mg in five. At 10 mg/mL a tirzepatide draw is typically 25 to 150 units, against 2.5 to 24 units for semaglutide, which is why tirzepatide needs a larger syringe or a stronger vial more often and semaglutide needs finer syringe marks. Tirzepatide acts on both GIP and GLP-1 receptors; semaglutide acts on GLP-1 only. For the semaglutide steps and vial maths, see the Semaglutide dose calculator.
Frequently asked questions
Dosing guide
Learn about tirzepatide dose escalation, injection preparation, and vial concentration selection in the full reference guide. Tirzepatide Dosing Guide →
Other calculators
Related guides
How this is calculated
This calculator divides your prescribed dose by the vial concentration to find the injection volume, then converts that volume to insulin-syringe units (volume in mL × 100 for a U-100 syringe). It is arithmetic only — nothing you enter is stored or sent anywhere, and the result is not medical advice. Always confirm your dose with your prescriber.
References
- ZEPBOUND (tirzepatide) Prescribing Information — dose titration — FDA / DailyMed, 2023
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — N Engl J Med, 2022
- FDA Concerns With Unapproved GLP-1 Drugs Used for Weight Loss (incl. compounded tirzepatide) — U.S. FDA
- FDA Green List: Protecting Americans From Illegal Imported GLP-1 Drug Ingredients — U.S. FDA
Citations are provided for transparency and education. They do not imply the cited authors or bodies endorse this tool. Always confirm dosing with your prescriber.